Matthew Brougham, Vice-President, Products and Services
Matthew Brougham is the Vice-President, Products and Services, at the Canadian Agency for Drugs and Technologies in Health (CADTH). Having joined CADTH in September 2011, he is responsible for overseeing the research, development, and delivery of the Agency’s products and services that contribute to the optimal use of drugs and health technologies in Canada.
He is also responsible for collaborating with other organizations that conduct health technology assessments, in Canada and abroad.
As the former Chief Executive of PHARMAC in New Zealand, Matthew has significant expertise in maximizing the health benefits of pharmaceuticals through the use of objective economic assessment and prioritization processes to support evidence-based decision-making.
Matthew’s professional experience covers a wide range of policy areas, including fisheries science, transportation, social welfare, health economics, and taxation. He maintains involvement in a number of organizations, including the International Network of Agencies for Health Technology Assessment (INAHTA) and Health Technology Assessment International (HTAi).
Matthew has an academic background in economics and science, which he studied at the University of Tromsø (Norway), and at Lincoln and Canterbury Universities (New Zealand).